Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections

Patent metadata

Field	Value
Publication number	US-8945567-B2
Application number	US-201013375357-A
Country	US
Kind code	B2
Filing date	Jun 7, 2010
Priority date	Jun 5, 2009
Publication date	Feb 3, 2015
Grant date	Feb 3, 2015

Abstract

Amino acid sequences are provided that are directed against and/or that can specifically bind protein F of hRSV, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. The amino acid sequences, polypeptides and therapeutic compounds and compositions provided by the invention show an improved stability, less immunogenicity and/or improved affinity and/or avidity for protein F of hRSV. The invention also relates to the uses of such amino acid sequences, polypeptides, compounds or constructs for prophylactic and/or therapeutic purposes.

First claim

The invention claimed is:

1. A polypeptide consisting of an amino acid sequence comprising or consisting of SEQ ID NO:142.

2. A composition, comprising the polypeptide according to claim 1 .

3. The composition according to claim 2 , wherein the composition is a pharmaceutical composition.

4. The pharmaceutical composition according to claim 3 , wherein the pharmaceutical composition comprises a carrier suitable for pulmonary delivery.

5. A method for the treatment of hRSV infection, said method comprising administering to a subject in need thereof a pharmaceutically effective amount of the polypeptide according to claim 1 .

6. The method of claim 5 , wherein the hRSV infection is a lower respiratory tract infection.

7. A pharmaceutical device suitable for the pulmonary delivery of a polypeptide, wherein the pharmaceutical device comprises the polypeptide according to claim 1 .

8. The pharmaceutical device according to claim 7 , wherein the pharmaceutical device is a nebulizer.

Assignees

• Depla Erik
• Stortelers Catelijne
• Staelens Stephanie
• Ablynx Nv

Inventors

• Depla Erik
• Stortelers Catelijne
• Staelens Stephanie

Classifications

• A61P31/14

  for RNA viruses · CPC title

• A61P29/00

  Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

• A61P11/14

  Antitussive agents · CPC title

• A61P11/04

  for throat disorders · CPC title

• A61P11/00

  Drugs for disorders of the respiratory system · CPC title